Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06513923
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-05
Brief Title:
Comparison of Remimazolam and Propofol on Emergence in Elderly Orthopedic Patients Under General Anesthesia
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparative Study of Remimazolam Remimazolam Plus Flumazenil vs Propofol Anesthesia on Emergence Time in Elderly Patients Undergoing Hip Replacement A Randomized Double Blinded Controlled Study
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Purpose This study aims to compare the emergence time among three anesthesia regimens remimazolam remimazolam with flumazenil and propofol in elderly patients undergoing hip replacement surgery
Background Previous studies have shown that flumazenil accelerates emergence time when used with remimazolam Remimazolam and propofol have comparable emergence times although remimazolam can be up to 5 minutes longer than propofol
Background Previous studies have shown that flumazenil accelerates emergence time when used with remimazolam Remimazolam and propofol have comparable emergence times although remimazolam can be up to 5 minutes longer than propofol
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None